Your nephrologist should be involved in managing your tirzepatide therapy, and regular eGFR and UACR monitoring is essential
What is Acetyl L-Carnitine?Acetyl L-Carnitine, also known as ALCAR, is a highly bioavailable form of the Amino Acid L-Carnitine
Key points to consider when interpreting the evidence: Most studies are short-term , typically lasting fewer than 12 weeks, making it difficult to assess long-term efficacy or safety Results appear more pronounced in older adults or individuals with obesity, compared to younger, healthy populations L-carnitine alone, without dietary or lifestyle changes , is unlikely to produce clinically meaningful weight loss Neither NICE nor the NHS recommends L-carnitine supplementation as part of any weight management pathway
This division underscores the complex considerations behind coverage decisions, as stakeholders weigh the clinical realities of obesity against beliefs about personal responsibility and concerns about long-term benefit
In non-diabetic individuals with overweight or obesity, with an average BMI of approximately 38, liraglutide administered at a dose of 3.0 mg per day for 56 weeks resulted in an 8% weight loss [10]
Activity modification during treatment is essential for optimal results